Medpage Today on MSN2d
FDA Adds New Warning to GLP-1 DrugsLabels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...
HealthDay on MSN4d
Medicaid covers GLP-1 weight-loss drugs in just 13 statesOnly 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
Dallas Morning News on MSN2d
FDA adds new warning to weight loss drugs including WegovyThe FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...
Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
For Sprackling, the key to consumers benefiting from GLP-1 medications is responsible use rather than viewing them as a quick ...
Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?
Health on MSN6d
Smoothie King Has a New 'GLP-1 Support Menu'—What People on Obesity Drugs Need to KnowSmoothie King, a franchise that specializes in selling smoothies, recently launched a "GLP-1 Support Menu," made specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback